Tirzepatide Online

Compounding is a long-standing, regulated pharmacy practice. A licensed provider must prescribe it and a licensed pharmacy must prepare it, and availability can change with FDA guidance, so eligibility is confirmed during your consultation.

You can start online through telehealth, but tirzepatide always requires a prescription. A licensed clinician reviews your health information and prescribes only if treatment is appropriate for you; a state-licensed compounding pharmacy then prepares your medication and ships it to you.

Compounded tirzepatide is as low as $119/mo, and the price is the same at every dose. Your plan includes your consultation, medication if prescribed, supplies, and shipping.

A state-licensed compounding pharmacy that follows applicable USP and regulatory standards prepares and ships your prescription.

No. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or manufacturing.

If you miss your weekly dose, take it within a few days if you can; if your next dose is near, skip the missed one and resume your schedule. Never double up, and follow your provider's instructions.

Many people notice reduced appetite within the first weeks. Visible weight change usually builds over 8–12 weeks as the dose is increased.

As a once-weekly subcutaneous injection on the same day each week, at any time of day, with or without food.

Into the fatty tissue of the abdomen, thigh, or upper arm. Rotate sites each week to reduce irritation.

Treatment typically starts at 2.5 mg weekly for four weeks, a tolerance-building dose that is not intended for weight maintenance.

Usually by 2.5 mg about every four weeks, as tolerated, until you reach an effective dose. Your provider controls the schedule.

The highest studied dose is 15 mg weekly, though many people do well on a lower dose.

Yes. Tirzepatide requires a valid prescription from a licensed provider; it is not available over the counter.

You complete a secure questionnaire, a licensed provider reviews it, and if appropriate they issue a prescription — all without an in-person visit.

Tirzepatide is prescribed to support appetite control, weight loss, and blood sugar regulation.

It activates GLP-1 and GIP receptors to reduce appetite, slow stomach emptying, and improve how the body handles sugar and fat, so you naturally eat less.

Both are gut hormones. GLP-1 mainly curbs appetite and slows digestion; GIP adds effects on insulin sensitivity and fat and sugar metabolism. Tirzepatide targets both.

The best choice depends on your health profile and your provider's assessment.

Individual results vary and compounded products are not separately studied.

Some weight regain is common after stopping any weight medication if habits don't change. Your provider can help you plan a long-term strategy.

Your provider determines what is appropriate for you.

Nausea, constipation, diarrhea, fatigue, and injection-site reactions — usually mild and most noticeable after dose increases.

Most are mild and temporary. Rare but serious effects exist (such as pancreatitis or gallbladder problems); seek care promptly for severe symptoms.

Eat smaller, lower-fat meals, stop when full, stay hydrated, and avoid heavy or greasy foods. Slow titration also helps; tell your provider if it persists.

It can, because it slows digestion. Fiber, fluids, and regular movement usually help; ask your provider if it continues.

Rapid weight loss from any cause can sometimes trigger temporary shedding. Adequate protein and nutrition help, and it typically resolves.

In animal studies it caused thyroid C-cell tumors; human risk is unknown. It should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2.

People who are pregnant or breastfeeding, or who have a history of medullary thyroid carcinoma or MEN 2, generally should not. Your provider reviews your full history.

No. Tirzepatide is not recommended during pregnancy or breastfeeding. Tell your provider if you are pregnant or planning to be.

Moderate alcohol may worsen nausea or blood sugar swings. Discuss your habits with your provider.

It can, particularly insulin and sulfonylureas (raising low-blood-sugar risk) and oral medications whose absorption is affected by slower digestion. Share your full medication list.

The medication works best with reasonable nutrition, adequate protein, and regular activity. It supports your efforts rather than replacing them.

Follow the pharmacy's instructions — typically refrigerated and protected from light. Do not freeze, and check your specific labeling.

No. Compounded tirzepatide costs the same at every dose, as low as $119/mo.

Your medication, the online consultation and prescription, ongoing provider support and dose adjustments, a home injection kit, and free discreet shipping.

Yes. Your plan is a subscription that bundles your medication, clinical care, and shipping, as low as $119/mo. Review renewal and cancellation terms at checkout.

After approval, your prescription is prepared and shipped in discreet packaging. Timing can vary by state and pharmacy; you'll get tracking details.

Availability varies by state and can change with regulations. Your eligibility is confirmed during the online consultation.

Yes. Dose and plan adjustments are part of ongoing care — message your care team through your dashboard.

Contact your provider. They may adjust your dose, slow titration, or recommend strategies to manage symptoms. Seek urgent care for severe symptoms.

Some patients may be asked for labs depending on their history. Your provider will let you know what's needed.

Generally a BMI of 30+, or 27+ with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea. A provider makes the final call.

Eligibility is based on BMI and health criteria, not cosmetic goals. A provider determines whether treatment is appropriate for you.

Obesity is treated as a chronic condition, so many people use it long-term under supervision. Your provider helps plan duration and maintenance.

Often yes, under provider guidance, with an appropriate starting dose. Don't switch on your own — your provider will plan the transition.

It promotes glucose-dependent insulin release, so the risk of low blood sugar is low in people without diabetes who aren't taking insulin or sulfonylureas.

Many users report less hunger and quieter “food noise,” which makes it easier to eat smaller portions.

It contains a well-studied active molecule, but compounded products are not FDA-reviewed and carry the same class risks. A provider weighs the benefits and risks for you.

Compounded tirzepatide is made by a licensed pharmacy from regulated ingredients to a prescription. Counterfeit products are illegal, unregulated, and unsafe — only obtain medication through a licensed provider and pharmacy.

Complete the short online intake, get reviewed by a licensed provider, and if approved your medication ships to your door. Tap Get Started to begin.